What is the Sana Biotechnology Inc (SANA) price today?

The price of Sana Biotechnology Inc (SANA) today is $3.5. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/SANA

Buy & Sell Sana Biotechnology Inc (SANA) – Sana Biotechnology Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

Sana Biotechnology (SANA) trades at $3.52, up 1.44% on the day, as the clinical-stage biotech focuses on its hypoimmune cell therapies. The stock shows strong analyst support with 9 out of 11 analysts rating it a Buy, citing a consensus price target of $8.00 (Defense World, 2026-03-27). Recent quarterly earnings have shown a mix of beats and misses, while the company reported positive 12-month clinical results for its UP421 type 1 diabetes study (GlobeNewsWire, 2026-03-03).

The investment thesis hinges on clinical validation of its lead programs, particularly SC451, with an IND planned for 2026 (Seeking Alpha, 2026-01-19). While analyst sentiment is bullish, the company is pre-revenue with significant cash burn, reflected in negative ROE and ROA. Key risks include early-stage trial failures, manufacturing scalability, and dependence on future capital raises to fund operations.

Read full analysis

Key Stats

Market Cap
$936.70M
Sector
Health
3M Drawdown
-46.4%
Enterprise Value
$877.18M
Dividend Yield
-

$3.5

52W Low: $1.59

21 Apr 2025

52W High: $5.92

15 Oct 2025

Sana Biotechnology Inc (SANA) is currently valued at a market capitalization of $936.70M, with an enterprise value of $877.18M. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $1.59 and a high of $5.92, highlighting its annual price range. Over the past three months, Sana Biotechnology Inc has recorded a drawdown of -46.4%, reflecting recent price volatility.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Technical Indicators

Overall Summary

Bearish (3)Neutral (10)Bullish (10)

News

Benzinga8 mon ago

Sana Biotechnology Announces Pricing of Public Offering

Globe Newswire8 mon ago

Sana Biotechnology Announces Pricing of Public Offering

Globe Newswire9 mon ago

Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors

Benzinga1 year ago

SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Globe Newswire1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$936.70M
Sector
Health
3M Drawdown
-46.4%
Enterprise Value
$877.18M
Dividend Yield
-

$3.5

52W Low: $1.59

21 Apr 2025

52W High: $5.92

15 Oct 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Sana Biotechnology Inc (SANA) – Sana Biotechnology Inc Price Today

Aura AI Summary

Key Stats

About Sana Biotechnology Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store